Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep 18;5(3):330-40.
doi: 10.1159/000438858. eCollection 2015 Sep-Dec.

Cognitive Rehabilitation of Dementia in Adults with Down Syndrome: A Review of Non-Pharmacological Interventions

Luciana Mascarenhas Fonseca  1 , Anna Carolina Rufino Navatta  2 , Cássio M C Bottino  1 , Eliane Correa Miotto  3
Affiliations
Review

Cognitive Rehabilitation of Dementia in Adults with Down Syndrome: A Review of Non-Pharmacological Interventions

Luciana Mascarenhas Fonseca et al. Dement Geriatr Cogn Dis Extra. .

Abstract

Background: There is a close genetic relationship between Alzheimer's disease (AD) and Down syndrome (DS), AD being the most severe mental disorder affecting ageing individuals with DS. The objective of the present study was to evaluate the efficacy of cognitive rehabilitation interventions in DS patients with AD by means of a critical literature review.

Summary: Because AD is progressive and irreversible, treatment is aimed at delaying and reducing the cognitive and functional decline in order to preserve or improve quality of life. The effects that pharmacological treatments and cognitive interventions have on elderly individuals with AD are well documented. Recent clinical trials have investigated the use of pharmacological treatment in DS patients with AD, generating preliminary results that have been unfavourable.

Key messages: There is a clear lack of studies addressing the efficacy of cognitive rehabilitation interventions in DS patients with AD, and there is an urgent need for studies providing evidence to inform decisions regarding the appropriate choice of treatment strategies.

Keywords: Alzheimer's disease; Dementia; Down syndrome; Early intervention; Geriatrics; Rehabilitation; Therapeutics.

PubMed Disclaimer

References

    1. Bottino CMC. Lessons from the epidemiology of neuropsychiatric disorders in older people. Arq Neuropsiquiatr. 2012;70:165–166. - PubMed
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. ed 5. Arlington: American Psychiatric Association; 2013.
    1. Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, Kazui H, Hashimoto R, Tanaka T, Kudo T, Yamagata H, Tabara Y, Miki T, Akatsu H, Kosaka K, Funakoshi E, Nishitomi K, Sakaguchi G, Kato A, Hattori H, Uema T, Takeda M. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease. Hum Mol Genet. 2007;16:15–23. - PubMed
    1. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer Disease in Down's syndrome. Ann Neurol. 1985;17:278–282. - PubMed
    1. Zigman WB. Atypical aging in Down syndrome. Dev Disabil Res Rev. 2013;18:51–67. - PubMed

LinkOut - more resources